MarketInOut Stock Screener Log In | Sign Up

Haleon Plc

LSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Haleon Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeLSE
Market Capitalization32,894 mln
Float8,397 mln
Earnings Date03/04/2027

EPS

18.00
Robust

P / E

17.74
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.57
Likely reliable

Relative Strength

4 / 100
Severely lagging

Debt / Equity

0.50
Moderate leverage

Business Description

Haleon is a UK-based consumer healthcare company that sells a wide range of everyday health products to customers across the world. Its portfolio covers oral care, vitamins and supplements, cold and flu remedies, pain relief, and digestive health, with well-known brands including Sensodyne, Centrum, Advil, Panadol, Voltaren, and Flonase. With roots stretching back to 1715, Haleon operates across North America, Europe, Asia, and beyond, helping people manage their health through products available without a prescription.

Key Fundamentals

EPS18.00
P/E17.74
ROE9.99
RPS1.25
ROIC6.79
ROA5.02
Interest Cover8.20
EBITDA, mln2,802
EV / EBITDA14.79
EV / EBIT16.91
Revenue, mln11,152
EV / Revenue3.72

Quote Details

Last 319.40
Change 1.7 (0.54%)
Open 322.20
Volume 43,572,276
Turnover 13,916,984,320
Average Volume 29,650,058

Financial Ratios

Pre-Tax Profit Margin19
Leverage Ratio1.99
Current Ratio0.69
Price / Book2.01
Price / Cash Flow21.90
Price / Free Cash Flow16.64
Debt / Equity0.50
Price / Sales3.02
PEG Ratio1.97

Financial Strength

Altman Z-Score2.51
Piotroski F-Score 7 / 9
Beneish M-Score-2.57
Price to Lynch Fair Value2.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.21% 1 / 100   
1 Month -2.56% 36 / 100   
2 Months -13.15% 12 / 100   
6 Months -3.73% 29 / 100   
1 Year -7.98% 21 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog